Timefolio Asset Management

Curiosis, Inc. is a South Korea-based company founded in 2015 that specializes in developing advanced instruments for life sciences research. The company offers a range of products, including cell counting systems like Facscope and imaging solutions such as Celloger Mini, which facilitate cell monitoring and time-lapse image recording. Curiosis utilizes innovative technologies, including microfabrication for the mass production of plastic microchips and calibration-free optical sensing for onboard image analysis, to enhance research capabilities. In addition to its instruments, the company provides consumables like C-Slide and CurioSlide products. With a team of expert scientists and engineers, Curiosis is committed to delivering high-efficiency solutions that support advancements in medical diagnostics and research.

Vueron specializes in advanced LiDAR perception software tailored for automotive and industrial applications, aiming to enhance safety through innovative technology. The company develops high-performance, AI-driven algorithms that allow for efficient object detection around LiDAR sensors while utilizing minimal computing resources. Vueron's solutions are designed for immediate integration into advanced driver-assistance systems (ADAS) and autonomous driving technologies, providing critical data on various elements such as lanes, guardrails, and potential obstacles. Additionally, the company offers a software development toolkit for IoT applications, focusing on security and smart city solutions. By collaborating with automotive original equipment manufacturers (OEMs), Tier-1 suppliers, and other industry stakeholders, Vueron delivers practical and cost-effective LiDAR solutions that meet diverse client needs.

Rapeech is an artificial intelligence voice technology company that specializes in product development services. Formerly known as Yespeech Co Ltd, Rapeech focuses on creating innovative solutions that leverage advanced voice recognition and processing technologies. The company aims to enhance user experiences across various applications by integrating its AI-driven voice capabilities into products and services. Through its expertise in voice technology, Rapeech is positioned to meet the growing demand for sophisticated voice interaction tools in multiple industries.

DEEPX is a South Korean company specializing in artificial intelligence solutions, focusing on both software and hardware systems. It develops advanced neural networks that enhance AI silicon for deep learning operations. By maximizing memory bandwidth, DEEPX's technology allows edge devices to operate efficiently, supporting the latest AI applications while promoting sustainable power usage. This approach enables businesses to implement energy-efficient on-device AI technology, streamlining their operations and improving performance.

Avelos Therapeutics is a clinical-stage precision medicine company that specializes in the development of biomarker-driven anti-cancer therapies. The company focuses on creating targeted therapeutics that address critical areas such as cell cycle regulation, DNA damage response, and undruggable cancer targets. By leveraging these innovative approaches, Avelos aims to enhance the effectiveness of cancer treatment, allowing healthcare professionals to provide more tailored and efficient care to patients.

Lillem is a manufacturing company specializing in the research, development, and production of materials for lithium secondary batteries. It focuses on creating innovative pouch films that enhance battery performance, offering proprietary technology that boosts capacity and stability, ensuring high-performing and reliable batteries for its customers.

TGS is a manufacturing company that designs copper-carbon composite materials and heat spreader for the oil and gas industry.

DEEPX is a South Korean company specializing in artificial intelligence solutions, focusing on both software and hardware systems. It develops advanced neural networks that enhance AI silicon for deep learning operations. By maximizing memory bandwidth, DEEPX's technology allows edge devices to operate efficiently, supporting the latest AI applications while promoting sustainable power usage. This approach enables businesses to implement energy-efficient on-device AI technology, streamlining their operations and improving performance.

DAAN Biotherapeutics focuses on developing innovative cancer treatments, particularly for lung cancer. The company conducts research and development in immune-oncology, utilizing advanced strategies such as anticancer immune cell therapy that employs natural killer (NK) cells and T cell receptors. DAAN Biotherapeutics aims to create effective therapies by integrating various treatment modalities, including cell therapies, antibodies, and small molecule inhibitors. Their work involves conducting clinical trials based on independent research infrastructure, with the objective of providing healthcare providers with effective options for treating cancer patients.

Mound Media is a media company offering content, music, video, picture, and text.

Mezoo is a medical device manufacturing company focused on developing biomedical sensor technology aimed at enhancing human health through accurate diagnoses. The company has created a compact, patch-type electrocardiogram that can be affixed to a patient’s chest. This device monitors heart activity in real-time, allowing physicians to effectively manage and prevent heart disease. By providing essential health data, Mezoo's technology supports healthcare professionals in delivering timely and informed medical care.

Gosung Engineering specializes in engineering services and products designed for various industries, including flat panel displays, semiconductors, secondary batteries, solar energy, and automobiles. The company develops a range of solutions, such as controllers, flow meters, sensors, power supplies, and advanced robotic systems. By leveraging its technological expertise, Gosung Engineering aims to deliver innovative solutions that enhance operational efficiency and contribute positively to society through ethical management and social responsibility.

Enhans operates an artificial intelligence-based analytics platform designed to support brands in various aspects of their business. The company offers services such as data analysis, automation, acquisition, and advertising, which are essential for overseas product sourcing and business growth. Its platform enables shopping and wholesale companies to enhance their decision-making processes by providing data insights related to market trends and user engagement. By focusing on flexible automation, Enhans allows businesses to scale their operations efficiently and respond quickly to market demands.

Brexogen is a biotechnology company focused on the research and development of cell therapies aimed at treating incurable diseases through the use of stem cell exosomes. The company specializes in creating optimized parental cells that enhance exosome production, exhibiting superior proliferation and secretion capabilities compared to traditional stem cells. This innovation allows for a more effective system for mass production of exosomes, which is essential for advancing their commercialization. Brexogen’s work aims to provide new therapeutic options for patients suffering from challenging medical conditions.

Primemas is a semiconductor startup headquartered in New York, with an R&D center located in Seoul. The company specializes in the development of low-cost, high-performance Hub Chiplet System-on-Chip (SoC) modules, known as Hublets, which are designed for the growing chiplet industry. These Hublets utilize high-bandwidth, low-latency device-to-device (D2D) interfaces, facilitating efficient infrastructure sharing with custom partner dies. This versatility makes them suitable for various markets, including CXL, artificial intelligence, cryptocurrency, and data analytics. By leveraging Primemas Hublets, clients can significantly reduce both the cost and time required to design and manufacture custom SoCs, achieving efficiencies that can be as much as tenfold.

IMBiologics is a biotechnology company focused on developing immunomodulatory antibody drugs aimed at achieving physiological balance. The company specializes in creating novel treatment options for autoimmune diseases and cancer through its innovative antibody-based biologics. By utilizing unique mechanisms of action to modulate the immune system, IMBiologics enables advancements in cancer treatment and enhances the potential for new therapeutic strategies in the field of modern biomedicine.

KevinLAB is a company focused on energy management systems. It has developed a platform that integrates smart metering to enhance energy efficiency. By collecting and analyzing real-time data related to energy applications and facilities within buildings, KevinLAB's platform enables clients to effectively manage their energy consumption and improve facility efficiency. Additionally, it assists in controlling the indoor environment, thereby contributing to more sustainable energy practices.

Next Square operates in the energy sector, specializing in power electronics and information and communication technology (ICT). The company designs and manufactures a range of products, including DC/AC inverters tailored for energy storage systems, DC microgrids, and AC system connections. Additionally, Next Square plays a significant role in the E-Mobility industry by providing parts for electric vehicle inspection and power converters that leverage advanced structural design and control technology. Their products are recognized for their reliability and stability, supported by various certifications. Overall, Next Square aims to deliver technology-driven solutions for electric-based vehicles and energy systems.

GigaVis is a manufacturing company that specializes in industrial machinery, particularly focusing on equipment for the semiconductor industry. The company develops automated optical inspection (AOI) systems and repair equipment (AOR), which are essential for ensuring the quality and reliability of semiconductor substrates. GigaVis's product offerings include automated optical inspection systems, vision inspection systems, and factory automation systems, catering to the needs of modern manufacturing processes. Through its innovative solutions, GigaVis plays a crucial role in enhancing operational efficiency and product quality in the semiconductor sector.

Avelos Therapeutics is a clinical-stage precision medicine company that specializes in the development of biomarker-driven anti-cancer therapies. The company focuses on creating targeted therapeutics that address critical areas such as cell cycle regulation, DNA damage response, and undruggable cancer targets. By leveraging these innovative approaches, Avelos aims to enhance the effectiveness of cancer treatment, allowing healthcare professionals to provide more tailored and efficient care to patients.

LUNASOFT INC. is a South Korean company founded in 2016, specializing in the development of chatbots and integrated management platforms aimed at enhancing customer support. The company offers a range of solutions, including Luna Plus, a courier exchange platform; Luna Plus Mobile, which facilitates real-time business consultations; and Luna Plus CTI, a customer counseling platform that combines phone and intelligent chat counseling. Additionally, LUNASOFT develops customer consultation chatbots tailored for popular messaging platforms such as Naver and Kakao, primarily catering to e-commerce businesses. Based in Seoul, LUNASOFT is focused on providing innovative chat solutions to improve customer interaction and support processes.

New Base provides a systematic disaster training solution.

Point2 Technology, founded in 2016 and based in Seoul, South Korea, specializes in developing advanced connectivity solutions aimed at meeting the growing bandwidth demands of 5G and cloud-based data centers. The company focuses on creating dielectric waveguide technology that enables high-speed, short-range interconnectivity. Its products are designed to deliver reliable, low-cost, and low-power solutions, facilitating efficient point-to-point connections for data center applications. By addressing the critical needs of modern infrastructure, Point2 Technology positions itself as a key player in enhancing data connectivity for the future.

Monday OFF is a mobile game developer and publisher located in South Korea.

Atoplex is a home test system and diagnosis platform using molecular immunodiagnosis technology.

TAKEONE Studio creates and develops original IP addresses for various media and entertainment content. It provides digital access to brands' films, web novels, and games.

IVIM Technology, Inc. specializes in the development and manufacture of advanced IntraVital Microscopy platforms and related medical devices. Based in Daejeon, South Korea, the company was founded in 2017 and focuses on live cell intravital imaging, which allows for the monitoring of drug efficacy and delivery in real-time within living organisms. Its technology enables the analysis of cellular interactions and the complex processes underlying human diseases, particularly in the context of new biopharmaceuticals, including immunological, cell, gene, and antibody therapies. IVIM Technology's services include whole tissue 3D imaging, providing comprehensive insights into drug performance at the cellular level.

DoubleMe, Inc. specializes in 3D capture technology, offering innovative solutions that bridge the gap between the physical and virtual worlds. Founded in 2014 and headquartered in San Jose, California, the company has developed the HoloPortal, a system that transforms 2D videos into 3D models in real-time, catering to diverse markets including gaming, animation, virtual and augmented reality, and 3D printing. Additionally, DoubleMe provides Voxelo, a viewpoint video player for Windows that allows users to experience 3D content of real captured scenes. The company captures both dynamic subjects like humans and animals, as well as static objects such as furniture, enabling the creation of animated and still 3D models. With operations in Sunnyvale, London, and Seoul, and partnerships with 15 telecommunications companies worldwide, DoubleMe continues to enhance its technology and expand its reach in the realm of social holographic reality experiences. The company has raised over $17 million in funding to support its mission of democratizing 3D technology.

SPARK BioPharma Co., Ltd. was established in Seoul National University in January 2016 based on the unique drug molecule diversity technology, the image-based screening technology using the unique fluorescent skeleton probe, and the target protein identification technology in the initial drug development stage. We are currently exploring and developing new drug candidates using these three core technologies, and we will continue to accelerate the development of new drugs and increase the success rate through strategic cooperation research with domestic and overseas research institutes and pharmaceutical institutions. '

Buying Square is a luxury B2B platform startup that connects businesses in Asia with over 3,000 luxury brands across various sectors, including fashion, sports, beauty, and lifestyle. The platform simplifies the sourcing, purchasing, and order management processes for luxury goods by providing access to verified suppliers through a strong network of local partners. It features comprehensive line sheets detailing information on luxury brands, including options for pre-order and in-stock items. By offering an efficient order management system, Buying Square equips businesses with the necessary resources to optimize their operations and enhance their purchasing experience.

DAAN Biotherapeutics focuses on developing innovative cancer treatments, particularly for lung cancer. The company conducts research and development in immune-oncology, utilizing advanced strategies such as anticancer immune cell therapy that employs natural killer (NK) cells and T cell receptors. DAAN Biotherapeutics aims to create effective therapies by integrating various treatment modalities, including cell therapies, antibodies, and small molecule inhibitors. Their work involves conducting clinical trials based on independent research infrastructure, with the objective of providing healthcare providers with effective options for treating cancer patients.

Hulam Pro is a labour management company.

iN Therapeutics is a biotechnology company focused on developing innovative drug therapies for patients with incurable neurological diseases. The company is engaged in the creation of treatments targeting various conditions, including non-narcotic analgesics for Nav1.7, hearing loss, and other brain-related disorders. By advancing its drug development pipeline, iN Therapeutics aims to provide effective solutions for central nervous system diseases, ultimately enhancing the quality of life for affected individuals.

Cyrus Therapeutics is a biotechnology company based in Seoul, South Korea, focused on the research and development of innovative drugs aimed at addressing chronic and life-threatening diseases, particularly those related to metabolic conditions, obesity, and refractory issues. Founded in 2019, the company utilizes various drug modalities, including traditional small molecule inhibitors and targeted protein degraders, to create medicines for patients with high unmet medical needs. Through its advanced technology, Cyrus Therapeutics aims to develop effective treatments for conditions that are often considered undruggable.

AI Korea is a company engaged in the development and supply of advanced technological components, including semiconductors, LCDs, OLEDs, and automation equipment. Additionally, it manufactures precision parts essential for battery production, focusing on providing electrolyte supply device systems for secondary batteries. The company also offers specialized equipment such as dust collectors, atmospheric pressure plasma dry cleaning systems, and ultrasonic dry cleaning solutions tailored for research and development applications. Through its diverse product offerings and commitment to meeting client needs, AI Korea positions itself as a key player in the technology and manufacturing sectors.

Victex is a manufacturer specializing in dry ice washing systems and operates its own dry ice production plant. The company is dedicated to supplying dry ice and has established a customer support center staffed with professional personnel to facilitate the immediate implementation of its systems across the country. This approach ensures that businesses have easy access to a reliable supply of dry ice, supported by localized parts and services. Victex aims to provide a stable supply chain to meet the needs of its customers efficiently.

Vueron specializes in advanced LiDAR perception software tailored for automotive and industrial applications, aiming to enhance safety through innovative technology. The company develops high-performance, AI-driven algorithms that allow for efficient object detection around LiDAR sensors while utilizing minimal computing resources. Vueron's solutions are designed for immediate integration into advanced driver-assistance systems (ADAS) and autonomous driving technologies, providing critical data on various elements such as lanes, guardrails, and potential obstacles. Additionally, the company offers a software development toolkit for IoT applications, focusing on security and smart city solutions. By collaborating with automotive original equipment manufacturers (OEMs), Tier-1 suppliers, and other industry stakeholders, Vueron delivers practical and cost-effective LiDAR solutions that meet diverse client needs.

Organoid Sciences is a drug development company based in Seongnam-si, South Korea, founded in 2018. The company specializes in organoid-based treatments and utilizes cannabinoid-based technology to create drugs aimed at addressing various incurable diseases. In addition to drug development, Organoid Sciences provides drug screening services and focuses on regenerative medicine, contributing to advancements in healthcare solutions.

Animal Industry Data Korea is a livestock healthcare solution provider company.

StradVision, Inc. specializes in developing advanced perception algorithms designed to enhance the capabilities of vehicles in recognizing and understanding their surroundings. Founded in 2014 and headquartered in Seoul, South Korea, with additional offices in California, Japan, India, China, and Germany, the company provides solutions such as SVNet External for external vehicle perception and SVNet Internal for monitoring driver and passenger status. StradVision's technology supports advanced driver assistance systems and autonomous vehicle applications, utilizing camera-based perception AI and LiDAR to ensure safety and accuracy in real-time object detection and classification. The company has achieved notable rankings in technology evaluations and holds over 60 issued patents, with more than 150 pending, reflecting its commitment to innovation in the automotive sector. Its auto labeling tool enhances data training efficiency, minimizing the need for human intervention and facilitating the development of reliable self-driving capabilities.

Robot Global Team is a manufacturing and development company that develops robots.

Tomocube Inc. specializes in the design and manufacture of 3D optical microscopes, particularly the HT-1 and HT-2 models, which offer holotomographic imaging and 3D fluorescence capabilities. Founded in 2015 and headquartered in Daejeon, South Korea, the company aims to enhance biological and medical research through innovative optical solutions. Unlike traditional optical microscopes that provide only 2D views, Tomocube's products enable researchers to obtain real-time, dynamic 3D images of living cells without the need for extensive sample preparation. This technology is particularly beneficial for studying various biological samples, including red blood cells, sperm cells, CAR-T cells, and more. By utilizing deep learning-based image recognition, Tomocube's microscopes allow for a better understanding of cellular dynamics, ultimately aiding in the diagnosis and treatment of human diseases.

CORELINESOFT develops medical software products.

Colavo Salon is a rapidly growing customer management software company that caters to independent beauty professionals. Its platform streamlines back-office operations by automating tasks, which allows salon owners to focus on client engagement. Colavo's software offers a range of features, including online reservations, schedule management, sales tracking, and report generation, all designed to enhance operational efficiency. By implementing intelligent booking and customizable reminders, the platform has been shown to improve customer retention by up to 50%. This comprehensive approach enables beauty professionals to manage their entire business processes from a single, user-friendly platform.

SCAI Therapeutics is a bio-venture company focused on developing drug delivery technology aimed at enhancing bioavailability in pharmaceuticals. Its proprietary platform offers innovative solutions that improve the efficacy of drugs, allowing clients in the pharmaceutical industry to validate and optimize their products. By providing a versatile approach to drug delivery, SCAI Therapeutics seeks to make significant advancements in the effectiveness of medications.

New Base provides a systematic disaster training solution.

InCerebro is a pharmaceutical research and development company that offers drug development.

PROTEINA specializes in advanced technologies for protein interaction analysis and cancer diagnosis. Their SPID Platform allows for the precise detection and analysis of protein interactions at the single-molecule level, providing valuable insights into the molecular mechanisms behind biological processes. This innovative approach is particularly beneficial in fields such as drug discovery, diagnostics, and basic research. Additionally, PROTEINA has developed a technology aimed at cancer diagnosis that detects drug resistance signals by observing the real-time activation of cancer signal pathways through relevant proteins. This capability enables healthcare professionals to predict drug efficacy effectively, enhancing treatment strategies for cancer patients.

Pharos iBio Co. is a biotechnology company focused on the development of innovative treatments for rare and intractable diseases. Leveraging a novel drug development platform that incorporates big data and artificial intelligence technology, the company aims to address significant medical needs. Among its product candidates are PHI-101-AML, targeting refractory or relapsed acute myeloid leukemia; PHI-101-OC, designed for patients with platinum-resistant or refractory ovarian cancer; and PHI-101-TNBC, aimed at treating metastatic triple-negative breast cancer. Additionally, the company is advancing several other candidates, including PHI-201, PHI-301, and PHI-501. Through its targeted approach, Pharos iBio seeks to contribute to the advancement of treatment options in oncology.

iN Therapeutics is a biotechnology company focused on developing innovative drug therapies for patients with incurable neurological diseases. The company is engaged in the creation of treatments targeting various conditions, including non-narcotic analgesics for Nav1.7, hearing loss, and other brain-related disorders. By advancing its drug development pipeline, iN Therapeutics aims to provide effective solutions for central nervous system diseases, ultimately enhancing the quality of life for affected individuals.

DEEPX is a South Korean company specializing in artificial intelligence solutions, focusing on both software and hardware systems. It develops advanced neural networks that enhance AI silicon for deep learning operations. By maximizing memory bandwidth, DEEPX's technology allows edge devices to operate efficiently, supporting the latest AI applications while promoting sustainable power usage. This approach enables businesses to implement energy-efficient on-device AI technology, streamlining their operations and improving performance.

Hisense Bio offers treatment for intractable dental diseases. They provide research on original technology for tooth development and dentin regeneration. They developed physiological dentin regeneration technology and periodontal ligament regeneration technology based on basic dental research . They offer treatment of intractable dental diseases such as tooth decay, dental hypersensitivity, tooth decay, dental caries, and periodontal disease.

Localstitch, founded in 2013 and based in South Korea, operates as a provider of shared office and residential spaces. The company aims to create environments where individuals can live, work, and launch businesses. By designing and managing flexible spaces, Localstitch facilitates collaboration among professionals while offering affordable rates that alleviate the financial burdens often associated with urban living. This approach allows clients to concentrate on their creative endeavors in a supportive community setting.

AbTis is a biotechnology company specializing in antibody-drug conjugation technology and drug solubilization. Its innovative approach aims to enhance the safety and efficacy of existing antibody-drug conjugates without the need for modifications to the antibodies themselves. This technology is applicable to native antibodies, commercial antibodies, and novel antibodies that are still under development. By providing a means for medical professionals to access effective antibody-drug conjugates, AbTis contributes to advancements in targeted therapies in the medical field.

Aston Sci is a clinical-stage biopharmaceutical company that develops medicines in oncology, immunology, and geriatrics.

Rebus Biosystems, Inc. is a life science technology company based in Santa Clara, California, specializing in spatial omics tools. The company has developed the Rebus Esper, an automated spatial omics platform that integrates advanced imaging, on-system chemistry, and user-friendly software to deliver quantitative data at subcellular resolution. This platform allows researchers to analyze biological molecules across large tissue sections while preserving spatial context. Rebus Biosystems focuses on automating microfluidics for sequential labeling of expressed transcripts, enabling high-resolution imaging that supports applications in pharmaceutical research, particularly in visualizing gene expression profiles in human brain tissues. Founded in 2006 and formerly known as Optical Biosystems, Rebus Biosystems continues to innovate in the realm of spatial omics to enhance research capabilities.

Kanaph Therapeutics Inc. is a biotechnology company focused on drug development, from discovery to early-stage clinical trials, primarily targeting oncology and autoimmune diseases. Founded in 2019 and headquartered in Seoul, South Korea, the company specializes in creating next-generation therapeutics, including bi-specific antibodies, Fc-fusions, and small molecules. Its oncology pipeline aims to improve immuno-stimulatory activity within the tumor microenvironment to enhance patient response rates for immuno-oncology treatments. Additionally, Kanaph Therapeutics develops therapeutic solutions for autoimmune conditions, utilizing bispecific Fc-fusions that inhibit pathways associated with complement activation and angiogenesis. The company operates in both Korea and the United States, striving to provide innovative treatments for complex diseases.

Cyrus Therapeutics is a biotechnology company based in Seoul, South Korea, focused on the research and development of innovative drugs aimed at addressing chronic and life-threatening diseases, particularly those related to metabolic conditions, obesity, and refractory issues. Founded in 2019, the company utilizes various drug modalities, including traditional small molecule inhibitors and targeted protein degraders, to create medicines for patients with high unmet medical needs. Through its advanced technology, Cyrus Therapeutics aims to develop effective treatments for conditions that are often considered undruggable.

ILIAS Biologics is a biotechnology company focused on developing exosome-based therapeutics. The company utilizes a platform technology that allows for the loading of large therapeutic molecules into exosomes, which are naturally occurring extracellular vesicles released by cells. This innovative approach aims to provide potential treatments for sepsis, pre-term birth, and various difficult-to-treat diseases, particularly in the inflammatory and metabolic domains. By harnessing the capabilities of exosomes, ILIAS Biologics seeks to advance drug development and improve therapeutic options for patients facing these challenging health issues.

StradVision, Inc. specializes in developing advanced perception algorithms designed to enhance the capabilities of vehicles in recognizing and understanding their surroundings. Founded in 2014 and headquartered in Seoul, South Korea, with additional offices in California, Japan, India, China, and Germany, the company provides solutions such as SVNet External for external vehicle perception and SVNet Internal for monitoring driver and passenger status. StradVision's technology supports advanced driver assistance systems and autonomous vehicle applications, utilizing camera-based perception AI and LiDAR to ensure safety and accuracy in real-time object detection and classification. The company has achieved notable rankings in technology evaluations and holds over 60 issued patents, with more than 150 pending, reflecting its commitment to innovation in the automotive sector. Its auto labeling tool enhances data training efficiency, minimizing the need for human intervention and facilitating the development of reliable self-driving capabilities.

Kanaph Therapeutics Inc. is a biotechnology company focused on drug development, from discovery to early-stage clinical trials, primarily targeting oncology and autoimmune diseases. Founded in 2019 and headquartered in Seoul, South Korea, the company specializes in creating next-generation therapeutics, including bi-specific antibodies, Fc-fusions, and small molecules. Its oncology pipeline aims to improve immuno-stimulatory activity within the tumor microenvironment to enhance patient response rates for immuno-oncology treatments. Additionally, Kanaph Therapeutics develops therapeutic solutions for autoimmune conditions, utilizing bispecific Fc-fusions that inhibit pathways associated with complement activation and angiogenesis. The company operates in both Korea and the United States, striving to provide innovative treatments for complex diseases.

Barogo provides a last-mile delivery platform to clients in order to generate new and creative business opportunities. It focuses on the ecosystem of connectivity and connects all possible businesses and customers. It was founded in 2014 and is based in Seoul, South Korea.

Hisense Bio offers treatment for intractable dental diseases. They provide research on original technology for tooth development and dentin regeneration. They developed physiological dentin regeneration technology and periodontal ligament regeneration technology based on basic dental research . They offer treatment of intractable dental diseases such as tooth decay, dental hypersensitivity, tooth decay, dental caries, and periodontal disease.

G+FLAS Life Sciences Co., Ltd., founded in 2014 and based in Seoul, South Korea, specializes in agricultural biotechnology with a focus on genome editing applications. Utilizing advanced CRISPR-Cas technology, the company develops innovative products such as glycoengineered humanized plants, which involve the selective removal of glycosylation-related genes. A flagship product is the vitamin D3-enriched tomato, aimed at enhancing nutritional value and addressing market demand for functional foods. This product not only serves the health-conscious consumer but also provides a plant-based alternative to traditional vitamin D supplements, catering to various dietary needs. G+FLAS has established a strategic partnership with Bayer, facilitating the commercialization of its technology and enhancing its position in the agricultural market. The company is also engaged in drug research and development, utilizing its gene therapy expertise to support healthcare organizations and pharmaceutical companies. G+FLAS Life Sciences is well-positioned for growth, targeting significant market share and aiming to accelerate expansion in the U.S. and beyond.

Fast Five is a premium SOHO office business center designed to provide attractive and efficient co-working spaces for startups and small-to-medium-sized companies. The company operates a membership-based model that allows members to access office spaces in high-demand locations without requiring a deposit. Fast Five aims to foster a sense of community among its members, facilitated by a community manager who helps build connections among founders, investors, professionals, and freelancers. The office environment is enhanced by communal perks such as free coffee, draft beer, and networking events, which promote collaboration and social interaction among members.